RecruitingPhase 4NCT04005378

Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs

Sponsor

Northwell Health

Enrollment

300 participants

Start Date

Jul 1, 2020

Study Type

INTERVENTIONAL

Conditions

First-episode Psychosis

Summary

Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participants still receiving care but at high risk for disengagement and to intervene to prevent/delay disengagement.

Eligibility

Min Age: 15 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying CSC Step-down intervention and Usual Care for people with first-episode psychosis. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 15 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCSC Step-down intervention

Web-based telemedicine and a smartphone app, to decrease disengagement likelihood

OTHERUsual Care

Usual Care provided by CSC center

Locations(3)

Henderson Behavioral Health

Lauderdale Lakes, Florida, United States

InterAct of Michigan

Grand Rapids, Michigan, United States

InterAct of Michigan

Kalamazoo, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04005378

Related Trials

Digital Strategies to Advance Help-Seeking - Aim 3

NCT067744171 location

Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode

NCT053843925 locations